Letter Sequence Other |
|---|
|
Results
Other: ML20338A160, ML20338A165, ML21026A001, ML21055A810, ML21055A820, ML21110A147, ML21110A148, ML21159A143, ML21187A126, ML21204A101, ML21309A105, ML22109A121, ML22200A061, ML22259A001, ML24040A176, ML24040A179, ML24044A062, ML24044A063
|
MONTHYEARML19221B7422019-08-30030 August 2019 Proprietary Determination Letter for ANP-10337, Revision 0, Supplement 1P, Revision 0, Deformable Spacer Grid Element RAI Response Project stage: RAI ML19347C1932019-12-10010 December 2019 Email Transmittal of Request for Additional Information Questions Regarding Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: RAI ML20083K3862020-03-26026 March 2020 Round 1 Request for Additional Information Questions for the Review of Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology (Non-Proprietary) Project stage: RAI ML20338A1652020-12-10010 December 2020 Regulatory Audit Plan for Framatome Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project No. 728 Project stage: Other ML20338A1602020-12-10010 December 2020 December 7 - 11, 2020, Regulatory Audit Plan for Framatome Inc. Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML21026A0012021-02-0909 February 2021 Audit Report Letter for Framatome Topical Report ANP-10229P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML21055A8102021-03-0101 March 2021 March 3, 4, 24, 25, and 26, 2021 Regulatory Audit Plan for Framatome Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project No. 728 EPID L-2018-TOP-0034 Project stage: Other ML21055A8202021-03-0101 March 2021 March 3, 4, 24, 25, and 26, 2021, Regulatory Audit Plan Letter for Framatome Inc. Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML21110A1472021-05-0404 May 2021 April 22, 2021, Audit Plan for Framatome Inc. Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology (EPID L-2018-TOP-0034) (Letter) Project stage: Other ML21110A1482021-05-0404 May 2021 April 22, 2021, Audit Plan for Framatome Inc. Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML21159A1432021-06-11011 June 2021 June 15, 2021, Regulatory Audit Plan for Framatome Inc. Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML21187A1262021-07-0909 July 2021 July 9, 2021 Audit Plan for Framatome Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML21204A1012021-07-27027 July 2021 August 11-12, 2021, Regulatory Audit Plan for Framatome Inc. Topical Report, ANP-10339P, Revision 0, Arita - ARTEMIS-RELAP Integrated Transient Analysis Methodology Project stage: Other ML21309A1052021-11-0808 November 2021 November 8, 2021 Audit Plan for Framatome Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML22109A1212022-04-22022 April 2022 April 20 - 21, and 28, 2022, Regulatory Audit Plan for Framatome Inc. Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML22097A2642022-04-26026 April 2022 U.S. Nuclear Regulatory Commissions Revised Schedule for Review of Framatome Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Approval ML22200A0612022-07-25025 July 2022 Report for 2021 - 2022, Regulatory Audits Regarding Framatome Inc. Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML22259A0012022-10-0505 October 2022 Schedule Change Letter for Framatome Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML22357A0822023-01-0909 January 2023 The U.S. Nuclear Regulatory Commissions Revised Schedule for the Review of Framatome’S Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Approval ML23006A2522023-01-17017 January 2023 Summary of Closed Hybrid Meeting with Framatome Inc. and the U. S. Nuclear Regulatory Commission for Topical Report, Anp 10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Meeting PMNS20230079, Closed Meeting with the Nuclear Regulatory Commission and Framatome Regarding Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology2023-01-30030 January 2023 Closed Meeting with the Nuclear Regulatory Commission and Framatome Regarding Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Request ML23072A3862023-04-0606 April 2023 Summary of March 2, 3023, Closed Meeting with Framatome Inc. and the U.S. Nuclear Regulatory Commission for Topical Report, ANP-10339P, Revision 0, ARITA-ARTEMIS/RELAP Integrated Transient Analysis Methodology Project stage: Meeting PMNS20230725, Closed Meeting with the Nuclear Regulatory Commission and Framatome Regarding Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology2023-06-0909 June 2023 Closed Meeting with the Nuclear Regulatory Commission and Framatome Regarding Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Request ML23177A2582023-07-10010 July 2023 Summary of June 20, 2023, Closed Meeting with Framatome Inc. and the U.S. Nuclear Regulatory Commission for Topical Report, Anp 10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Meeting PMNS20231147, Closed Meeting with the Nuclear Regulatory Commission and Framatome Regarding Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology2023-10-0606 October 2023 Closed Meeting with the Nuclear Regulatory Commission and Framatome Regarding Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Request ML23233A1392023-10-16016 October 2023 Final Safety Evaluation for Framatome Topical Report Anp 10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology (EPID L 2018-TOP-0034) Letter Project stage: Approval ML23299A2402023-10-16016 October 2023 Final Safety Evaluation for Framatome Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology (Appendix IV) - Non-Proprietary Project stage: Approval ML23299A2322023-10-16016 October 2023 Final Safety Evaluation for Framatome Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology - Non-Proprietary Project stage: Approval ML23305A0642023-11-0505 November 2023 Summary of October 19, 2023, Closed Meeting with Framatome Inc. and the U.S. Nuclear Regulatory Commission for Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Meeting ML24044A0632024-02-13013 February 2024 Transmittal Withholding Determination for Publication of Framatome Topical Report, ANP-10339P, Rev. 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML24044A0622024-02-13013 February 2024 Withholding Determination for Publication of Framatome Topical Report, ANP-10339P, Rev. 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML24040A1792024-04-16016 April 2024 Verification for Publication of Framatome Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Topical Report Project stage: Other ML24040A1762024-04-22022 April 2024 Verification for Publication of Framatome Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Transmittal (EPID L-2018-TOP-0034) - Email Project stage: Other 2022-04-26
[Table View] |
Text
Enclosure REGULATORY AUDIT PLAN FOR FRAMATOME INC.
TOPICAL REPORT, ANP-10339P, REVISION 0, ARITA - ARTEMIS/RELAP INTEGRATED TRANSIENT ANALYSIS METHODOLOGY PROJECT NO. 728 EPID: L-2018-TOP-0034
1.0 BACKGROUND
By letter dated August 28, 2018 (Agencywide Documents Access and Management System (ADAMS) Accession No. ML18242A443), Framatome, Inc. (Framatome) submitted Topical Report (TR) ANP-10339P, Revision 0, ARITA - ARTEMIS/RELAP Integrated Transient Analysis Methodology (ADAMS Package No. ML18242A480), to the U.S. Nuclear Regulatory Commission (NRC) for review and approval for licensing applications. ANP-10339P, Revision 0 (ARITA) presents a coupled code system and evaluation models for the analysis of pressurized water reactor (PWR) non-loss-of-coolant accident (LOCA) events identified in Chapter 15 of NUREG-0800 (Standard Review Plan). In December 2018, the NRC staff completed an acceptance review of the TR and found additional information was necessary (ADAMS Accession No. ML18345A159) before a formal review effort could begin. The necessary supplemental information was submitted by Framatome in March 2019 (ADAMS Accession No. ML19078A253). The NRC staffs review also relies upon information submitted by Framatome in March 2020, July 2020, and November 2020 (ADAMS Accession Nos. ML20097E381, ML20237F458, and ML20335A218, respectively) in response to request for additional information (RAI) questions from the NRC staff.
The NRC staff has identified that many of Framatomes RAI responses do not fully address the staffs concerns. Therefore, the NRC staff has proposed to conduct a regulatory audit at this point in the review process in an effort to increase efficiency in the review, facilitate discussion, and close the open items. The NRC staff will conduct this virtual audit under the guidance provided in LIC-500 (Topical Report Process) and LIC-111 (Regulatory Audits).
2.0 REGULATORY AUDIT BASES Regulatory guidance for the review of fuel system materials and designs and adherence to Title 10 of the Code of Federal Regulations, Appendix A to Part 50, General Design Criteria (GDC)-10, Reactor Design, GDC-27, Combined Reactivity Control Systems Capability, and GDC-35, Emergency Core Cooling, is provided in NUREG-0800, Standard Review Plan for the Review of Safety Analysis Reports for Nuclear Power Plants (SRP), Section 4.2, Fuel System Design. In accordance with SRP Section 4.2, the objectives of the fuel system safety review is to provide reasonable assurance that: (1) the fuel system is not damaged as a result of normal operation and anticipated operational occurrences (AOOs), (2) fuel system damage is never so severe as to prevent control rod insertion when it is required, (3) the number of fuel rod failures are not underestimated for postulated accidents, and (4) coolability is always maintained.
3.0 REGULATORY AUDIT SCOPE The NRC staff will conduct a five-day audit online. This audit is expected to include one day for discussion between the NRC staff and Framatome staff regarding areas of technical disagreement identified during the review and four days for NRC staff and Framatome staff to review open items from the RAI responses. Details regarding the discussions and open items are provided below.
4.0 INFORMATION NEEDS The NRC staff would like Framatome to make available the appropriate engineer(s) with intimate knowledge of ARITA and any appropriate references, to address any comprehension questions by the NRC staff.
Documents referenced in the TR should also be made available.
Major Discussion Topics The following are topics on which there appear to be fundamental differences in technical opinion between NRC staff and Framatome staff. These topics are intended to be discussed on the first day of the audit:
- 1. Discussion of meeting Regulatory Requirements (RAI questions 10, 11, 18, 57, and 62)
- 2. Legacy licensing basis issues: ARITA methodology may potentially be incompatible with plant bases developed using deterministic methods (RAI questions 15, 16, 17, and 21)
- 3. Framatome discussion on justification/necessity of sampling approach (RAI questions 18 and 62)
- 4. Reanalysis threshold and applicability of uncertainty distributions (RAI questions 13, 24, and 50)
Addressing Individual RAI questions Once discussion of the major topics above has occurred, the NRC staff will proceed to step through each individual RAI question and seek resolution of the associated concerns.
5.0 TEAM ASSIGNMENTS Kevin Heller, Technical Reviewer (NRR/DSS/SFNB)
John Lehning, Technical Reviewer (NRR/DSS/SFNB)
Joshua Kaizer, Technical Reviewer (NRR/DSS/SFNB)
Ngola Otto, Project Manager (NRR/DORL/LLPB)
Ken Geelhood, Pacific Northwest National Laboratory (PNNL)
Bruce Schmidt, PNNL Dave Engle, PNNL 6.0 LOGISTICS Audit Dates: Monday, December 7, 2020 - Friday, December 11, 2020.
Time will be allocated for specific topics during each day of the audit as presented below:
Table 1: Audit Agenda Monday Tuesday Wednesday Thursday Friday AM Major Discussion Topics / RAI Questions
RAI 9
Detailed RAI Discussion Detailed RAI Discussion Revisit Topics as Needed / To Be Determined PM Major Discussion Topics / RAI Questions RAI 9 / Draft future RAI Responses Detailed RAI Discussion Recap of Potential Limitations &
Conditions Revisit Topics as Needed / To Be Determined Framatome should provide details for using an online platform which supports video call for the performing the audit (e.g., WebEx) or confirm that it is able to use the platform that can be provided by the NRC (i.e., Microsoft Teams).
7.0 DELIVERABLES A regulatory audit summary will be provided within 90 days of the completion of the audit.